Vasileios Lioutas is originally from Thessaloniki, Greece. He attended Medical School in the Aristotle University of Thessaloniki School of Medicine. He completed his Neurology residency at Boston University Medical Center and subsequently received his subspecialty training in Vascular Neurology at Beth Israel Deaconess Medical Center/Harvard Medical School in Boston where he currently is on faculty with the rank of Assistant Professor and also serves as Assistant Director of the Vascular Neurology Fellowship. He is Board Certified in Neurology, Vascular Neurology (American Board of Psychiatry and Neurology) and Neurosonology (American Society of Neuroimaging).
He has a strong interest in Stroke Epidemiology and has been a Framingham Heart Study Investigator in the Neurology group since 2016. He is also an investigator at the Black Women’s Health Study and the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC) at the Boston VA system. His main areas of focus are intracerebral haemorrhage, cerebral small vessel disease and its impact on functional and cognitive performance and dementia. He has also served as site PI in several industry and NIH-sponsored multicenter trials.
He has published more than 50 peer-reviewed articles including recent original studies in the epidemiology of Transient Ischemic Attack (JAMA, 2021) and Intracerebral Hemorrhage (JAMA Neurology, 2020). He edited the 2nd Edition of Stroke at the “What Do I Do Now” series with Dr Louis Caplan (Oxford University Press, 2016).
He is a member of the American Heart Association, the American Academy of Neurology, European Stroke Organisation and the World Stroke Organization. He served as the CME and Highlights Editor in the Stroke from 2015-2020 and remains a member of the journal’s editorial board. He is an ad hoc reviewer for several journals, including Neurology, Annals of Neurology, JAMA Neurology.
Achieving our vision of a life free from stroke is a task that WSO cannot achieve alone. We are committed to building our partnerships at the global, regional and national level to scale up and deliver improvements in prevention, treatment and support to reduce the burden of stroke.
With support from:
*All WSO educational programs are independently developed and delivered.